About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials in Dallas | 556 Studies

Clinical Trials Breast CancerDallas

Breast Cancer Clinical Trials in Dallas

Find 556 clinical trials for breast cancer near Dallas, Texas. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Dallas

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 41-60 of 556 trials

RecruitingBortezomib Followed by Pembrolizumab and Cisplatin in metTNBCThe hypothesis of this pilot trial is that administration of bortezomib will inhibit NHEJ in metastatic TNBC leading at the time of disease progression to metastases that are…NCT04265872·Dallas, Texas CompletedA Study Evaluating Safety and Efficacy of the Addition of ABT-888 Plus Carboplatin Versus the Addition of Carboplatin to Standard Chemotherapy Versus Standard Chemotherapy in Subjects With Early Stage Triple Negative Breast CancerThis is a 3 arm Phase 3 study to evaluate the safety and efficacy of the addition of veliparib plus carboplatin versus the addition of carboplatin to standard neoadjuvant…NCT02032277·Scottsdale, Arizona and 157 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedStudy to Compare the Effects of Repeated Doses of an Investigational New Drug and a Placebo on Appetite in Advanced Cancer and AnorexiaStudy to compare the effects of the investigational new drug (PF-06946860) and a placebo on appetite and to find out how participants with advanced cancer and anorexia feel after…NCT04803305·Little Rock, Arkansas and 32 others

CompletedSentiMag® Intraoperative Comparison in Breast CancerThe purpose of this pivotal study is to provide prospective evidence that the SentiMag®/SiennaXP® is safe and non-inferior to the current standard of care for lymph node…NCT02336737·La Jolla, California and 5 others

WithdrawnTest - Retest Reproducibility of 18F Fluoroestradiol (FES) PETThis study will formally address the hypothesis that FES-PET/CT measurement of ER expression predicts clinical benefit of first-line endocrine therapy in newly diagnosed ER+…NCT03065712·Dallas, Texas

CompletedSafety and Efficacy of TKI258 in FGFR1 Amplified and Non-amplified Metastatic HER2 Negative Breast CancerThe purpose of this trial is to determine the efficacy and safety profile of TKI258 in 3 groups of patients with metastatic HER2 negative breast cancer (BC) stratified by FGFR1…NCT00958971·Bakersfield, California and 37 others

RecruitingPrecision Medicine in Action: Phase II Trial of Response Adaptive Ablative Pre-operative SPBI (RAPS) and Non-operative Sentinel Lymph Node Biopsy in Patients With Early-stage ER+ Breast Cancer: RAPS Trial1\. Efficacy of PULSAR preoperative radiation 2.NCT06444269·Dallas, Texas

CompletedSWOG-9342 Chemotherapy in Treating Women Enrolled in the SWOG-8897 Clinical TrialRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00002900·Mobile, Alabama and 104 others

CompletedPazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Advanced Or Metastatic Breast CancerThis study is being conducted to compare the efficacy and safety of pazopanib in combination with lapatinib with that of lapatinib alone in subjects with locally advanced or…NCT00347919·Jonesboro, Arkansas and 83 others

TerminatedPhase 1b/2 Study of TTI-101 in Combination for Patients With Metastatic Hormone Receptor-Positive and HER2-Negative Breast CancerThe primary objective of Phase 1b will be to evaluate the safety and tolerability of TTI-101 when added to palbociclib and AI or fulvestrant administered orally to participants…NCT05384119·Fort Lauderdale, Florida and 5 others

CompletedStudy to Evaluate the Efficacy, Safety, and Tolerability of E7070 in Metastatic Breast Cancer PatientsThe purpose of this study is to determine if E7070 is an efficacious, safe, and tolerable treatment for patients with metastatic breast cancer who have failed, or could not…NCT00080197·Birmingham, Alabama and 34 others

RecruitingSusan G. Komen's ShareForCuresShareForCures (SFC) is a community-based participatory research registry, and its prime objective is to engage participants representative of the United States breast cancer…NCT05654246·Dallas, Texas

CompletedFolate Receptor Alpha Peptide Vaccine With GM-CSF in Patients With Triple Negative Breast CancerThis Phase II trial evaluates the safety and immunogenicity of two doses of the Folate Receptor Alpha (FRα) peptide vaccine mixed with GM-CSF as a vaccine adjuvant, with or…NCT02593227·Tampa, Florida and 10 others

TerminatedA Study Evaluating Bemarituzumab in Solid Tumors With Fibroblast Growth Factor Receptor 2b (FGFR2b) OverexpressionThe primary objectives of this study are to observe the safety and tolerability of bemarituzumab and to evaluate preliminary antitumor activity.NCT05325866·Duarte, California and 114 others

TerminatedMycophenolate Mofetil (MMF) for Treatment of Chronic Graft-versus-host Disease (GVHD)RATIONALE: Mycophenolate mofetil added to immunosuppressive treatment regimens may be effective in treating newly diagnosed chronic graft-versus-host disease caused by stem cell…NCT00089141·Duarte, California and 15 others

CompletedStudy of the Combination of Vorinostat and Radiation Therapy for the Treatment of Patients With Brain MetastasesVorinostat in combination with radiation therapy can be administered safely and will be tolerated in patients with brain metastases, while providing an assessment of the…NCT00838929·Philadelphia, Pennsylvania and 1 other

CompletedStudy to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected CancersThe purpose of this study was to assess the safety, tolerability, and efficacy when combining MK-3475 and INCB024360 in participants with certain cancers.NCT02178722·La Jolla, California and 23 others

Active not recruitingPhase II Multi-center Trial Evaluating 5 Fraction Stereotactic Partial Breast Irradiation Using GammapodStereotactic radiation has been implemented more than 3 decades ago, initially to radiate benign and later malignant tumors within the brain.NCT03581136·Baltimore, Maryland and 1 other

CompletedDoxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2RATIONALE: Drugs used in chemotherapy, such as doxorubicin, cyclophosphamide, and paclitaxel, use different ways to stop tumor cells from dividing so they stop growing or die.NCT00004067·Huntsville, Alabama and 148 others

Active not recruitingA Study to Evaluate Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Malignant Solid Tumors (EV-202)The primary purpose of this study is to determine the antitumor activity of enfortumab vedotin as measured by confirmed objective response rate (ORR) per RECIST v1.1.NCT04225117·Tucson, Arizona and 38 others

PreviousPage 3 of 28Next

Other Conditions in Dallas

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma